These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

64 related articles for article (PubMed ID: 2789166)

  • 21. Analysis of recently activated, memory and naive lymphocyte T subsets in the peripheral blood of patients with Graves' disease and insulin-dependent diabetes mellitus.
    Kretowski A; Myśliwiec J; Turowski D; Wysocka J; Kinalska I
    Rocz Akad Med Bialymst; 1999; 44():226-34. PubMed ID: 10697437
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical value of M22-based assays for TSH-receptor antibody (TRAb) in the follow-up of antithyroid drug treated Graves' disease: comparison with the second generation human TRAb assay.
    Massart C; Gibassier J; d'Herbomez M
    Clin Chim Acta; 2009 Sep; 407(1-2):62-6. PubMed ID: 19576193
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evaluation of the 2nd generation radio-receptional assay for anti-TSH receptor antibodies (TRAb) in autoimmune thyroid diseases. Comparison with 1st generation and anti-thyroperoxidase antibodies (AbTPO).
    Giovanella L; Ceriani L; Garancini S
    Q J Nucl Med; 2001 Mar; 45(1):115-9. PubMed ID: 11456370
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Improved prediction of relapse of Graves' thyrotoxicosis by combined determination of TSH receptor and thyroperoxidase antibodies.
    Schott M; Eckstein A; Willenberg HS; Nguyen TB; Morgenthaler NG; Scherbaum WA
    Horm Metab Res; 2007 Jan; 39(1):56-61. PubMed ID: 17226115
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Differential immunosuppressive action of carbimazole and propylthiouracil.
    Wilson R; McKillop JH; Pearson C; Burnett AK; Thomson JA
    Clin Exp Immunol; 1988 Aug; 73(2):312-5. PubMed ID: 3263234
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Immunological aspects of Graves' disease patients in different clinical stages.
    Gauna A; Segura G; Sartorio G; Soto R; Segal-Eiras A
    J Endocrinol Invest; 1989 Nov; 12(10):671-7. PubMed ID: 2614006
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Association of immunoglobulin A deficiency and elevated thyrotropin-receptor autoantibodies in two Nordic countries.
    Jorgensen GH; Ornolfsson AE; Johannesson A; Gudmundsson S; Janzi M; Wang N; Hammarström L; Ludviksson BR
    Hum Immunol; 2011 Feb; 72(2):166-72. PubMed ID: 20977916
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Reactivation of persistent Epstein-Barr virus (EBV) causes secretion of thyrotropin receptor antibodies (TRAbs) in EBV-infected B lymphocytes with TRAbs on their surface.
    Nagata K; Nakayama Y; Higaki K; Ochi M; Kanai K; Matsushita M; Kuwamoto S; Kato M; Murakami I; Iwasaki T; Nanba E; Kimura H; Hayashi K
    Autoimmunity; 2015; 48(5):328-35. PubMed ID: 25759125
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ia+ T cells in new onset Graves' disease.
    Jackson RA; Haynes BF; Burch WM; Shimizu K; Bowring MA; Eisenbarth GS
    J Clin Endocrinol Metab; 1984 Aug; 59(2):187-90. PubMed ID: 6610685
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Inverse correlation between activated T cells and TSH receptor antibodies in Graves' disease.
    Kennedy RL
    Autoimmunity; 1989; 4(1-2):103-7. PubMed ID: 2491637
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Graves' disease: immunological and immunogenetic indicators of relapse.
    de Bruin TW; Bolk JH; Bussemaker JK; Stijnen T; Schreuder GM; de Vries RR; van der Heide D
    Br Med J (Clin Res Ed); 1988 May; 296(6632):1292-5. PubMed ID: 3133054
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A prospective study of the relationship between relapse of hyperthyroid Graves' disease after antithyroid drugs and HLA haplotype.
    Allannic H; Fauchet R; Lorcy Y; Gueguen M; Le Guerrier AM; Genetet B
    J Clin Endocrinol Metab; 1983 Oct; 57(4):719-22. PubMed ID: 6688428
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The ability of the serum thyrotrophin receptor antibody (TRAb) index and HLA status to predict long-term remission of thyrotoxicosis following medical therapy for Graves' disease.
    Wilson R; McKillop JH; Henderson N; Pearson DW; Thomson JA
    Clin Endocrinol (Oxf); 1986 Aug; 25(2):151-6. PubMed ID: 3491692
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Estradiol Affects Epstein-Barr Virus Reactivation-Induced Thyrotropin Receptor Antibody and Immunoglobulin Production in Graves' Disease Patients and Healthy Controls.
    Hara S; Nagata K; Kumata K; Matsushita M; Kuwamoto S; Kato M; Hayashi K
    Viral Immunol; 2018 Sep; 31(7):486-491. PubMed ID: 30133352
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [The role of circulating immune complexes in the pathogenesis of Graves' disease].
    Funauchi M
    Nihon Naibunpi Gakkai Zasshi; 1983 Dec; 59(12):1912-27. PubMed ID: 6325260
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Relapse in Basedow's disease after treatment with synthetic antithyroid drugs. Prognostic value of analysis of the HLA system].
    Allannic H; Fauchet R; Lorcy Y; Gueguen M; Le Guerrier AM; Genetet B
    Presse Med; 1983 Dec; 12(44):2797-800. PubMed ID: 6228849
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Occurrence of antibodies to insulin in patients with autoimmune thyroid disease.
    Ng WY; Thai AC; Lui KF; Cheah JS
    Ann Acad Med Singap; 1993 Jul; 22(4):544-8. PubMed ID: 8257055
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Analysis of T cell subsets in Graves' disease: alterations associated with carbimazole.
    Ludgate ME; McGregor AM; Weetman AP; Ratanachaiyavong S; Lazarus JH; Hall R; Middleton GW
    Br Med J (Clin Res Ed); 1984 Feb; 288(6416):526-30. PubMed ID: 6421364
    [TBL] [Abstract][Full Text] [Related]  

  • 39. DQA2 U allele: a genetic marker for relapse of Graves' disease.
    Ratanachaiyavong S; Gunn CA; Bidwell EA; Darke C; Hall R; McGregor AM
    Clin Endocrinol (Oxf); 1990 Feb; 32(2):241-51. PubMed ID: 1971775
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prediction of relapse in hyperthyroid Graves' disease.
    McGregor AM; Smith BR; Hall R; Petersen MM; Miller M; Dewar PJ
    Lancet; 1980 May; 1(8178):1101-3. PubMed ID: 6103438
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.